No Major Near-Term Shift in Express Scripts' (ESRX) Strategy Expected with New CEO Appointment - Evercore
Evercore ISI affirms Express Scripts (Nasdaq: ESRX) with a Hold rating and $97 price target following news that the company ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)